Prescription Analytics


Prescription Analytics is a company dedicated to helping pharmaceutical manufacturers achieve growth, profitability, and compliance objectives through services such as government pricing, rebate processing, licensing, and support services. Founded in 2010 by a group of lifelong friends with experience in managed care and life sciences, the company emphasizes long-term relationships, transparency, and accuracy in its operations.

Industries

consulting
life-science
pharmaceutical

Nr. of Employees

small (1-50)

Prescription Analytics


Services

Managed services for calculation, reconciliation and processing of government program rebates and regulatory pricing submissions.

Validation, processing and reconciliation of chargeback claims to prevent revenue leakage and support gross-to-net accuracy.

Support for obtaining and maintaining state-level product licenses and registrations required for commercialization.

Preparation and submission of state-mandated price transparency reports and assistance navigating state-specific requirements.

Integration with client commercial teams to support class-of-trade coding, order-to-cash processes, gross-to-net calculations and other commercial analytics.

On-demand analytic projects, forecasting models and specialized support for pricing, accruals and regulatory scenarios.

Expertise Areas

  • Government pricing and Medicaid rebate administration
  • Rebate reconciliation and payment processing
  • Chargeback processing and revenue leakage prevention
  • State price transparency reporting (SPTR)
  • Show More (5)

Key Technologies

  • Transaction-level payer data analytics
  • Rebate accrual and forecasting models
  • Regulatory reporting workflows for CMS (ASP/AMP)
  • Gross-to-net reconciliation processes
  • Show More (3)

News & Updates

Discussion on how the 2023 drug wastage regulation will affect pharmaceutical manufacturers.

CMS enforcement updates regarding Average Sales Price submissions for Medicare Part B pharmaceuticals.

Reminder about the upcoming deadline for the Branded Prescription Drug Fee payments.

A comprehensive guide on establishing and calculating the Baseline Average Manufacturer Price (AMP).

Details on the CMS Final Rule published on September 26, 2024, affecting pharmaceutical manufacturers.

An analysis of factors leading to high Medicaid rebates and how to manage rebate liabilities.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.